Sign in

CIK 0001802768

  • Large accelerated filer

Royalty Pharma plc

Sign in to watch
Ticker
RPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+1 212-883-0200
Business address
110 EAST 59TH STREET, NEW YORK, NY, 10022
  1. 4 Open-market sale EVP, Investments & CLO sold 192,221 shares at an average $33.70 ($6,478,587)
  2. 4 Open-market buy CEO, Chairman of the Board bought 150,000 shares at $32.25 ($4,837,440)
  3. 4 Open-market sale Director sold 1,750,000 shares at $32.82 ($57,435,000)
  4. 4 Open-market buy CEO, Chairman of the Board bought 230,000 shares at an average $33.38 ($7,676,824)
  5. 4 Derivatives Options or other derivatives
  6. 4 Conversion Director acquired 300,000 shares (conversion)
  7. 4 Grant or award Director acquired 1,049 shares (grant or award)
  8. 4 Grant or award Director acquired 1,049 shares (grant or award)
  9. 4 Open-market sale Director sold 139,950 shares at an average $36.31 ($5,081,111)
  10. 4 Open-market sale EVP, Investments & CLO sold 112,779 shares at an average $37.06 ($4,179,295)
  11. 4 Open-market sale EVP, Investments & CLO sold 25,000 shares at $37.27 ($931,658)
  12. 4 Open-market sale EVP, Research & Investments sold 23,333 shares at $37.30 ($870,239)
  13. 4 Conversion Director acquired 1,500,000 shares (conversion)
  14. 4 Conversion EVP, Research & Investments acquired 70,000 shares (conversion)
  15. 5 Insider Annual Insider Trading Report
  16. 4 Grant or award Director acquired 943 shares (grant or award)
  17. 4 Grant or award Director acquired 943 shares (grant or award)
  18. 4 Open-market sale Director sold 60,000 shares at an average $42.01 ($2,520,623)
  19. 4 Open-market sale Director sold 84,302 shares at $43.15 ($3,637,463)
  20. 4 Open-market sale Director sold 362,766 shares at an average $44.04 ($15,974,737)

Page 9 of 18 · 342 filings